Literature DB >> 11208514

Bladder cancer--genetic overview.

S Halachmi1, R Madeb, A Kravtsov, B Moskovitz, N Halachmi, O Nativ.   

Abstract

BACKGROUND: This article review the serial genetic changes which are responsible to the initiation and progression of bladder cancer. Knowledge of the exact genetic alteration has a direct implication on the development of knew more sensitive and specific tool for an early diagnosis and better prognosis calculations.
CONCLUSION: Bladder cancer develop and progress through a series of genetic alterations. Understanding of the genetic mechanisms which lead to malignant transformation gave rise to the development of various genetic mechanisms which lead to malignant transformation gave rise to the development of various genetic tools providing better ability of early detection and more accurate prognosis prediction.

Entities:  

Mesh:

Year:  2001        PMID: 11208514

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  2 in total

1.  Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in polish population.

Authors:  Elżbieta Złowocka-Perłowska; Aleksandra Tołoczko-Grabarek; Jan Lubiński
Journal:  Hered Cancer Clin Pract       Date:  2022-01-04       Impact factor: 2.857

2.  The Clinical Relevance of Fragile Histidine Triad Protein (FHIT) in Patients with Bladder Cancer.

Authors:  Xiao-Ping Liu; Xiao-Hong Yin; Xin-Hui Yan; Xian-Tao Zeng; Xing-Huan Wang
Journal:  Med Sci Monit       Date:  2018-05-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.